Literature DB >> 16474156

A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.

Ken Murata1, Toshihisa Hayashibara, Kazuyuki Sugahara, Akiko Uemura, Taku Yamaguchi, Hitomi Harasawa, Hiroo Hasegawa, Kazuto Tsuruda, Toshiro Okazaki, Takehiko Koji, Takayuki Miyanishi, Yasuaki Yamada, Shimeru Kamihira.   

Abstract

Adult T-cell leukemia (ATL) is associated with prior infection with human T-cell leukemia virus type 1 (HTLV-1); however, the mechanism by which HTLV-1 causes adult T-cell leukemia has not been fully elucidated. Recently, a functional basic leucine zipper (bZIP) protein coded in the minus strand of HTLV-1 genome (HBZ) was identified. We report here a novel isoform of the HTLV-1 bZIP factor (HBZ), HBZ-SI, identified by means of reverse transcription-PCR (RT-PCR) in conjunction with 5' and 3' rapid amplification of cDNA ends (RACE). HBZ-SI is a 206-amino-acid-long protein and is generated by alternative splicing between part of the HBZ gene and a novel exon located in the 3' long terminal repeat of the HTLV-1 genome. Consequently, these isoforms share >95% amino acid sequence identity, and differ only at their N termini, indicating that HBZ-SI is also a functional protein. Duplex RT-PCR and real-time quantitative RT-PCR analyses showed that the mRNAs of these isoforms were expressed at equivalent levels in all ATL cell samples examined. Nonetheless, we found by Western blotting that the HBZ-SI protein was preferentially expressed in some ATL cell lines examined. A key finding was obtained from the subcellular localization analyses of these isoforms. Despite their high sequence similarity, each isoform was targeted to distinguishable subnuclear structures. These data show the presence of a novel isoform of HBZ in ATL cells, and in addition, shed new light on the possibility that each isoform may play a unique role in distinct regions in the cell nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474156      PMCID: PMC1395368          DOI: 10.1128/JVI.80.5.2495-2505.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation.

Authors:  Kuan-Teh Jeang; Chou-zen Giam; Franca Majone; Mordechai Aboud
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

2.  Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs.

Authors:  Patrick Hivin; Mélissa Frédéric; Charlotte Arpin-André; Jihane Basbous; Bernard Gay; Sabine Thébault; Jean-Michel Mesnard
Journal:  J Cell Sci       Date:  2005-03-08       Impact factor: 5.285

3.  Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.

Authors:  Y Furukawa; R Kubota; M Tara; S Izumo; M Osame
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

4.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

5.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy.

Authors:  Toshihisa Hayashibara; Yasuaki Yamada; Susumu Nakayama; Hitomi Harasawa; Kazuto Tsuruda; Kazuyuki Sugahara; Takayuki Miyanishi; Shimeru Kamihira; Masao Tomonaga; Tetsuo Maita
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 7.  Human T-cell leukemia virus type I and adult T-cell leukemia.

Authors:  Masao Matsuoka
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

8.  The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Authors:  Jihane Basbous; Charlotte Arpin; Gilles Gaudray; Marc Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2003-08-22       Impact factor: 5.157

9.  An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential.

Authors:  Naoto Yoshizuka; Ryozo Moriuchi; Tsuyoshi Mori; Kenji Yamada; Sumitaka Hasegawa; Takahiro Maeda; Takako Shimada; Yasuaki Yamada; Shimeru Kamihira; Masao Tomonaga; Shigeru Katamine
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

10.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

View more
  67 in total

1.  The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.

Authors:  Gunjan Choudhary; Lee Ratner
Journal:  Virology       Date:  2010-12-21       Impact factor: 3.616

2.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

3.  Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.

Authors:  Osamu Isono; Takayuki Ohshima; Yasushi Saeki; Jun Matsumoto; Makoto Hijikata; Keiji Tanaka; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

4.  Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes.

Authors:  Mads Heilskov Rasmussen; Borja Ballarín-González; Jinghua Liu; Louise Berkhoudt Lassen; Annette Füchtbauer; Ernst-Martin Füchtbauer; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

5.  Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein.

Authors:  Sébastien Landry; Marilène Halin; Amandine Vargas; Isabelle Lemasson; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 6.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

7.  Enhanced Stabilization of MCL1 by the Human T-Cell Leukemia Virus Type 1 bZIP Factor Is Modulated by Blocking the Recruitment of Cullin 1 to the SCF Complex.

Authors:  Risa Mukai; Takayuki Ohshima
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

8.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

9.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

Review 10.  The HBZ gene, a key player in HTLV-1 pathogenesis.

Authors:  Masao Matsuoka; Patrick L Green
Journal:  Retrovirology       Date:  2009-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.